ConvaTec Group’s (CTEC) Add Rating Reaffirmed at Peel Hunt

ConvaTec Group (LON:CTEC)‘s stock had its “add” rating reissued by equities research analysts at Peel Hunt in a research report issued to clients and investors on Tuesday,Digital Look reports. They currently have a GBX 270 price objective on the stock. Peel Hunt’s price target indicates a potential upside of 17.19% from the stock’s previous close.

CTEC has been the subject of a number of other research reports. UBS Group restated a “buy” rating and set a GBX 375 price objective on shares of ConvaTec Group in a research report on Monday, May 18th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, April 8th. Citigroup decreased their target price on shares of ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a research report on Monday, May 18th. Berenberg Bank restated a “buy” rating and issued a GBX 340 target price on shares of ConvaTec Group in a research report on Tuesday, April 21st. Finally, JPMorgan Chase & Co. decreased their target price on ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating for the company in a research note on Friday, May 22nd. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of GBX 306.

ConvaTec Group Stock Performance

CTEC stock opened at GBX 230.40 on Tuesday. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 99.96. ConvaTec Group has a 12-month low of GBX 193 and a 12-month high of GBX 259.30. The stock’s 50 day simple moving average is GBX 211.20 and its 200 day simple moving average is GBX 221.13. The firm has a market cap of £4.50 billion, a P/E ratio of 26.79, a P/E/G ratio of 0.93 and a beta of 0.77.

Insider Activity

In related news, insider Jonny Mason acquired 50,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were purchased at an average cost of GBX 201 per share, with a total value of £100,500. 0.98% of the stock is owned by company insiders.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.